These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33563525)

  • 1. The optimal trough-guided monitoring of vancomycin in children: Systematic review and meta-analyses.
    Moriyama H; Tsutsuura M; Kojima N; Mizukami Y; Tashiro S; Osa S; Enoki Y; Taguchi K; Oda K; Fujii S; Takahashi Y; Hamada Y; Kimura T; Takesue Y; Matsumoto K
    J Infect Chemother; 2021 May; 27(5):781-785. PubMed ID: 33563525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing.
    Tsutsuura M; Moriyama H; Kojima N; Mizukami Y; Tashiro S; Osa S; Enoki Y; Taguchi K; Oda K; Fujii S; Takahashi Y; Hamada Y; Kimura T; Takesue Y; Matsumoto K
    BMC Infect Dis; 2021 Feb; 21(1):153. PubMed ID: 33549035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis.
    Steinmetz T; Eliakim-Raz N; Goldberg E; Leibovici L; Yahav D
    Clin Microbiol Infect; 2015 Jul; 21(7):665-73. PubMed ID: 25887712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta-analysis.
    Abdelmessih E; Patel N; Vekaria J; Crovetto B; SanFilippo S; Adams C; Brunetti L
    Pharmacotherapy; 2022 Sep; 42(9):741-753. PubMed ID: 35869689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Vancomycin Trough Serum Concentrations and Clinical Outcomes in Children: a Systematic Review and Meta-Analysis.
    Cao L; Li Z; Zhang P; Yong S
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0013822. PubMed ID: 35862741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment.
    Hirai T; Hanada K; Kanno A; Akashi M; Itoh T
    Eur J Clin Pharmacol; 2019 Jun; 75(6):859-866. PubMed ID: 30770940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.
    Chuma M; Makishima M; Imai T; Tochikura N; Suzuki S; Kuwana T; Sawada N; Komatsu T; Sakaue T; Kikuchi N; Yoshida Y; Kinoshita K
    Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial.
    Bosso JA; Nappi J; Rudisill C; Wellein M; Bookstaver PB; Swindler J; Mauldin PD
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5475-9. PubMed ID: 21947388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotoxicity With Vancomycin in the Pediatric Population: A Systematic Review and Meta-Analysis.
    Fiorito TM; Luther MK; Dennehy PH; LaPlante KL; Matson KL
    Pediatr Infect Dis J; 2018 Jul; 37(7):654-661. PubMed ID: 29280786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and meta-analysis to explore optimal therapeutic range of vancomycin trough level for infected paediatric patients with Gram-positive pathogens to reduce mortality and nephrotoxicity risk.
    Kato H; Hagihara M; Okudaira M; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
    Int J Antimicrob Agents; 2021 Aug; 58(2):106393. PubMed ID: 34174409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal trough concentration of teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus infection: A systematic review and meta-analysis.
    Hanai Y; Takahashi Y; Niwa T; Mayumi T; Hamada Y; Kimura T; Matsumoto K; Fujii S; Takesue Y
    J Clin Pharm Ther; 2021 Jun; 46(3):622-632. PubMed ID: 33547647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.
    Hermsen ED; Hanson M; Sankaranarayanan J; Stoner JA; Florescu MC; Rupp ME
    Expert Opin Drug Saf; 2010 Jan; 9(1):9-14. PubMed ID: 20021290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
    Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Mogle BT; Steele JM; Seabury RW; Dang UJ; Kufel WD
    Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
    Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
    Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit.
    Cies JJ; Shankar V
    Pharmacotherapy; 2013 Apr; 33(4):392-400. PubMed ID: 23471688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of an AUC
    Chavada R; Ghosh N; Sandaradura I; Maley M; Van Hal SJ
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Area-Under-Curve-Guided Versus Trough-Guided Monitoring of Vancomycin and Its Impact on Nephrotoxicity: A Systematic Review and Meta-Analysis.
    Lim AS; Foo SHW; Benjamin Seng JJ; Magdeline Ng TT; Chng HT; Han Z
    Ther Drug Monit; 2023 Aug; 45(4):519-532. PubMed ID: 36728329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis.
    Zhang Y; Wang T; Zhang D; You H; Dong Y; Liu Y; Du Q; Sun D; Zhang T; Dong Y
    Ther Drug Monit; 2020 Aug; 42(4):600-609. PubMed ID: 32097248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low vancomycin trough concentration in neonates and young infants.
    Maruyama H; Tanzawa A; Funaki T; Ito Y; Isayama T
    Pediatr Int; 2021 May; 63(5):556-560. PubMed ID: 32894884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.